Teefey Sharlene A, Hildeboldt Charles C, Dehdashti Farrokh, Siegel Barry A, Peters Marion G, Heiken Jay P, Brown Jeffrey J, McFarland Elizabeth G, Middleton William D, Balfe Dennis M, Ritter Jon H
Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S Kingshighway Blvd, St Louis, MO 63110, USA.
Radiology. 2003 Feb;226(2):533-42. doi: 10.1148/radiol.2262011980.
To determine and compare the diagnostic performance of computed tomography (CT), magnetic resonance (MR) imaging, ultrasonography (US), and positron emission tomography (PET) in the detection of hepatocellular carcinoma (HCC) or cholangiocarcinoma in liver transplant candidates and to determine interobserver variability between the readers.
Twenty-five patients were examined prospectively with CT, MR imaging, US, and PET. Each test result was interpreted independently by two radiologists. Explanted liver specimens were examined histologically to determine presence and type of lesion. Results were analyzed on a patient-by-patient basis with marginal homogeneity and effect likelihood ratio tests.
HCC was diagnosed in nine patients. US diagnostic performance was superior to that of CT and MR imaging on a patient-by-patient basis. Sensitivities were higher for US (0.89 for both US readers) than they were for CT (0.67 and 0.56 for readers 1 and 2, respectively), MR imaging (0.56 and 0.50 for readers 1 and 2, respectively), and PET (0 for both readers). None of the differences (within test) between readers were significant (P >or=.32). Ratings by US and MR observers and one CT observer were significantly associated with truth (P <or=.04). One or more imaging tests depicted 68 lesions. Histologic analysis revealed 18 HCC nodules; of these, 13 were correctly identified at CT, 14 at MR imaging, 13 at US, and none at PET. There were nine false-positive diagnoses of HCC with CT, five with MR imaging, and nine with US.
Although US had the best diagnostic performance in depicting HCC on a patient-by-patient basis and was substantially better than were MR imaging and CT (which had nearly equivalent diagnostic performances), CT, US, and MR imaging performed similarly on a lesion-by-lesion basis. Small tumor nodules were the most common cause of missed HCCs with all tests. PET did not depict any HCCs.
确定并比较计算机断层扫描(CT)、磁共振成像(MR)、超声检查(US)和正电子发射断层扫描(PET)在检测肝移植候选者肝细胞癌(HCC)或胆管癌中的诊断性能,并确定阅片者之间的观察者间变异性。
对25例患者进行了CT、MR成像、US和PET的前瞻性检查。每项检查结果由两名放射科医生独立解读。对切除的肝脏标本进行组织学检查以确定病变的存在和类型。基于患者逐一分析结果,采用边际齐性检验和效应似然比检验。
9例患者被诊断为HCC。在逐一分析患者时,US的诊断性能优于CT和MR成像。US的敏感性(两位US阅片者均为0.89)高于CT(阅片者1为0.67,阅片者2为0.56)、MR成像(阅片者1为0.56,阅片者2为0.50)和PET(两位阅片者均为0)。阅片者之间(在同一项检查内)的差异均无统计学意义(P≥0.32)。US和MR观察者以及一名CT观察者的评级与实际情况显著相关(P≤0.04)。一项或多项成像检查显示了68个病变。组织学分析发现18个HCC结节;其中,CT正确识别出13个,MR成像正确识别出14个,US正确识别出13个,PET未识别出任何结节。CT有9例假阳性HCC诊断,MR成像有5例,US有9例。
尽管在逐一分析患者时,US在描绘HCC方面具有最佳诊断性能,且明显优于MR成像和CT(二者诊断性能相近),但在逐一分析病变时,CT、US和MR成像表现相似。小肿瘤结节是所有检查中漏诊HCC的最常见原因。PET未显示任何HCC。